DE2709050A1 - Neue hydroxamsaeurederivate und arzneimittel gegen harnstein und pyelonephrose, welche diese derivate enthalten - Google Patents
Neue hydroxamsaeurederivate und arzneimittel gegen harnstein und pyelonephrose, welche diese derivate enthaltenInfo
- Publication number
- DE2709050A1 DE2709050A1 DE19772709050 DE2709050A DE2709050A1 DE 2709050 A1 DE2709050 A1 DE 2709050A1 DE 19772709050 DE19772709050 DE 19772709050 DE 2709050 A DE2709050 A DE 2709050A DE 2709050 A1 DE2709050 A1 DE 2709050A1
- Authority
- DE
- Germany
- Prior art keywords
- group
- compound
- general formula
- compounds
- conh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6707776A JPS6029379B2 (ja) | 1976-06-10 | 1976-06-10 | 新規なヒドロキサム酸化合物およびこの化合物を主成分とする尿路結石症治療剤 |
| JP6707876A JPS52151158A (en) | 1976-06-10 | 1976-06-10 | Novel hydroxamic acid compound and remedies for lithangiuria containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2709050A1 true DE2709050A1 (de) | 1977-12-29 |
Family
ID=26408270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19772709050 Withdrawn DE2709050A1 (de) | 1976-06-10 | 1977-03-02 | Neue hydroxamsaeurederivate und arzneimittel gegen harnstein und pyelonephrose, welche diese derivate enthalten |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE2709050A1 (US07534539-20090519-C00280.png) |
| FR (1) | FR2354315A1 (US07534539-20090519-C00280.png) |
| GB (1) | GB1577345A (US07534539-20090519-C00280.png) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283637B1 (it) * | 1996-05-14 | 1998-04-23 | Italfarmaco Spa | Composti ad attivita' antinfiammatoria ed immunosoppressiva |
| US8372885B2 (en) * | 2008-09-17 | 2013-02-12 | Novartis Ag | Organic compounds and their uses |
-
1977
- 1977-03-02 GB GB888177A patent/GB1577345A/en not_active Expired
- 1977-03-02 DE DE19772709050 patent/DE2709050A1/de not_active Withdrawn
- 1977-03-02 FR FR7706072A patent/FR2354315A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2354315A1 (fr) | 1978-01-06 |
| FR2354315B1 (US07534539-20090519-C00280.png) | 1980-02-08 |
| GB1577345A (en) | 1980-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3204596C2 (US07534539-20090519-C00280.png) | ||
| DE3005164C2 (de) | 1,1-Dioxopenicillanoyloxymethyl-6-(D-α-amino-α-phenylacetamido)-penicillanat, Verfahren zu seiner Herstellung und es enthaltendes Arzneimittel | |
| EP0708640B1 (de) | Pharmazeutische zubereitungen mit einem wirkstoff, der modifizierte amidingruppen enthält | |
| CH615668A5 (US07534539-20090519-C00280.png) | ||
| DE3785740T2 (de) | Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie. | |
| CH644590A5 (de) | N-acetyl-para-aminophenyl-n'-acetylaminothiofettsaeureester-derivate. | |
| DE3687181T2 (de) | Knochengezielte inhibitoren der karbonischen anhydrase. | |
| DE69021466T2 (de) | Sulfonylhydrazine und deren Verwendung als antineoplastische und als antitrypanosomale Mittel. | |
| DE68915269T2 (de) | Polyvalentes entzündungshemmendes mittel. | |
| US4083996A (en) | Novel hydroxamic acid derivatives and medicaments for treatment of urolithiasis and pyelonephrosis comprising such derivatives | |
| EP0202673B1 (de) | Cytostatisch wirksame Titanocen-Komplexe | |
| DE2923334C2 (de) | Verwendung von Cyclopentadienylmetall-Acido-Komplexen bei der Krebsbekämpfung und diese Komplexe enthaltende Arzneipräparate | |
| DE69208569T2 (de) | Thioharnstoffderivate und sie enthaltendes, antimikrobielles und antiulcerogenes Mittel | |
| US4157396A (en) | Hydroxamic acid derivatives and medicaments for treatment of urolithiasis and pyelonephrosis comprising such derivatives | |
| CH642542A5 (de) | Arzneimittel, enthaltend eine kombination aus einem prolinderivat und einem diuretikum. | |
| DE69003670T2 (de) | Nicht einspritzbares karzinostatisches mittel zur vorbeugung der entzündung durch 5-fluoruracil und verfahren zur behandlung von krebs. | |
| DE2709050A1 (de) | Neue hydroxamsaeurederivate und arzneimittel gegen harnstein und pyelonephrose, welche diese derivate enthalten | |
| DE2937532A1 (de) | Hydroxamsaeureverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE3113150C2 (de) | Kristallines N,N'-Bis-(3-picolyl)-4-methoxy-isophthalamid-monohydrat, Verfahren zu seiner Herstellung und dieses enthaltende, pharmazeutische Mittel | |
| DE1768655B2 (US07534539-20090519-C00280.png) | ||
| DE3212817C2 (US07534539-20090519-C00280.png) | ||
| DE2535799C3 (de) | N'- [1 -(p-Chlorbenzoyl)-5-methoxy-2-methyl-3indolyl-acetoxy- alkyl] -N-(N-benzoyl- N'JS'-di-npropyl-DL-isoglutaminyloxy- alkyD-piperazine und diese enthaltene Entzündungen und Gelenksaffektionen hemmende Präparate | |
| DE3121175A1 (de) | Erythro-1,2,3-triphenyl-1-pentanon-derivate sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE3238726A1 (de) | Phosphoramidderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten | |
| DE2708327A1 (de) | Entzuendungshemmendes mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8141 | Disposal/no request for examination |